STOCK TITAN

MacroGenics to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company, announced participation in two investor conferences in August 2020. The BTIG Virtual Biotechnology Conference will feature one-on-one meetings and a fire-side chat on August 10 at 12:30 p.m. ET. The Wedbush PacGrow Healthcare Conference is set for August 12 at 8:35 a.m. ET, with similar one-on-one meetings and a corporate overview. Webcasts of both events will be available on the company's website for 30 days post-conference.

Positive
  • None.
Negative
  • None.

ROCKVILLE, MD, Aug. 05, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences in August: 

  • BTIG Virtual Biotechnology Conference. MacroGenics’ management will participate in one-on-one meetings and a fire-side chat discussion hosted by the analyst on Monday, August 10, 2020 at 12:30 p.m. ET.
  • Wedbush PacGrow Healthcare Conference. MacroGenics’ management will participate in one-on-one meetings and provide a corporate overview on August 12, 2020, at 8:35 a.m. ET.

Webcasts of each presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain archived replays of these webcasts on its website for 30 days after each conference.

About MacroGenics, Inc.

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

###

CONTACT:
Jim Karrels, Senior Vice President, CFO
MacroGenics, Inc.
1-301-251-5172, info@macrogenics.com

FAQ

What investor conferences will MacroGenics participate in August 2020?

MacroGenics will participate in the BTIG Virtual Biotechnology Conference on August 10 and the Wedbush PacGrow Healthcare Conference on August 12, 2020.

What time is MacroGenics' presentation at the BTIG Virtual Biotechnology Conference?

The presentation at the BTIG Virtual Biotechnology Conference is scheduled for August 10, 2020, at 12:30 p.m. ET.

When will MacroGenics provide a corporate overview at the Wedbush PacGrow Healthcare Conference?

MacroGenics will provide a corporate overview on August 12, 2020, at 8:35 a.m. ET.

Where can I access the webcasts of MacroGenics' conference presentations?

Webcasts of the presentations can be accessed under 'Events & Presentations' in the Investor Relations section of MacroGenics' website.

How long will the webcasts of MacroGenics' investor conferences be available?

The webcasts will be archived on MacroGenics' website for 30 days after each conference.

MacroGenics, Inc.

NASDAQ:MGNX

MGNX Rankings

MGNX Latest News

MGNX Stock Data

225.32M
62.72M
2.64%
101.03%
8.55%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
Rockville